174 related articles for article (PubMed ID: 8765409)
1. Progress in preclinical and clinical studies for the development of new anticancer drugs in Japan, with emphasis on taxanes.
Saijo N; Nishio K; Ohta S; Arioka H; Funayama Y; Fukuoka K; Kurokawa H; Nomoto T; Ishida T; Yamamoto N; Tamura T; Shinkai T; Eguchi K; Ohe Y; Kunito H; Ohtsu T; Sasaki Y
Cancer Chemother Pharmacol; 1996; 38 Suppl():S11-5. PubMed ID: 8765409
[No Abstract] [Full Text] [Related]
2. New drugs in non-small cell lung cancer. An overview.
Giaccone G
Lung Cancer; 1995 Apr; 12 Suppl 1():S155-62. PubMed ID: 7551924
[TBL] [Abstract][Full Text] [Related]
3. New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experience.
Saijo N
Chest; 1998 Jan; 113(1 Suppl):17S-23S. PubMed ID: 9438685
[TBL] [Abstract][Full Text] [Related]
4. Cost-utility analysis of chemotherapy using paclitaxel, docetaxel, or vinorelbine for patients with anthracycline-resistant breast cancer.
Leung PP; Tannock IF; Oza AM; Puodziunas A; Dranitsaris G
J Clin Oncol; 1999 Oct; 17(10):3082-90. PubMed ID: 10506603
[TBL] [Abstract][Full Text] [Related]
5. [New wave of chemotherapeutic agents: update in pulmonary oncology].
Sculier JP
Rev Mal Respir; 1997 Apr; 14(2):154-6. PubMed ID: 9198842
[No Abstract] [Full Text] [Related]
6. Role of taxanes in adjuvant therapy.
Münster PN; Hudis CA
Cancer Invest; 2000; 18(1):32-8. PubMed ID: 10701365
[No Abstract] [Full Text] [Related]
7. Single agents in the second-line treatment of non-small cell lung cancer.
Belani CP
Semin Oncol; 1998 Jun; 25(3 Suppl 8):10-4. PubMed ID: 9704670
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
[TBL] [Abstract][Full Text] [Related]
9. In the clinic: where paclitaxel and docetaxel stand.
McNeil C
J Natl Cancer Inst; 1995 Aug; 87(15):1107. PubMed ID: 7674312
[No Abstract] [Full Text] [Related]
10. [Vinorelbine in the treatment of non-small-cell lung cancer and breast cancer].
Kubota K
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1301-6. PubMed ID: 10945030
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel (Taxotere): a new anti-cancer drug with promising potential?
Verweij J
Br J Cancer; 1994 Aug; 70(2):183-4. PubMed ID: 7914419
[No Abstract] [Full Text] [Related]
12. Docetaxel in the management of advanced non-small cell lung cancer.
Miller VA
Semin Oncol; 1998 Jun; 25(3 Suppl 8):15-9. PubMed ID: 9704671
[TBL] [Abstract][Full Text] [Related]
13. A sequence-dependent combination of docetaxel and vinorelbine: pharmacokinetic interactions.
Cattel L; Recalenda V; Airoldi M; Tagini V; Arpicco S; Brusa P; Bumma C
Farmaco; 2001 Oct; 56(10):779-84. PubMed ID: 11718271
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer.
Georgoulias V; Kourousis C; Androulakis N; Kakolyris S; Papadakis E; Bouros D; Apostolopoulou F; Georgopoulou T; Agelidou M; Souglakos J; Halkiadakis G; Hatzidaki D
Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-9-S14-14. PubMed ID: 9335517
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of treatment options in advanced breast cancer in the UK.
Brown RE; Hutton J; Burrell A
Pharmacoeconomics; 2001; 19(11):1091-102. PubMed ID: 11735676
[TBL] [Abstract][Full Text] [Related]
16. [Paclitaxel (Taxol) and docetaxel (Taxotere): results of phase II trials in monochemotherapy].
Fumoleau P; Perrocheau G; Maugard-Louboutin C; Lemevel B
Bull Cancer; 1995 Aug; 82(8):629-36. PubMed ID: 7492819
[TBL] [Abstract][Full Text] [Related]
17. [Recent results of anticancer drugs acting on microtubules--navelbine, taxol and taxotere for the treatment of lung cancer].
Kawahara M; Furuse K
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2150-6. PubMed ID: 1359840
[No Abstract] [Full Text] [Related]
18. Review of recent trials of chemotherapy for advanced breast cancer: the taxanes.
Clemons M; Leahy M; Valle J; Jayson G; Ranson M; Howell A
Eur J Cancer; 1997 Nov; 33(13):2183-93. PubMed ID: 9470804
[No Abstract] [Full Text] [Related]
19. Taxing the taxanes: overused or undersold?
Miller M
J Natl Cancer Inst; 1999 Dec; 91(24):2077-8. PubMed ID: 10601377
[No Abstract] [Full Text] [Related]
20. Clinical trials referral resource. Clinical trials with Docetaxel (Taxotere).
Cheson BD; Arbuck SG; Phillips PH
Oncology (Williston Park); 1993 Sep; 7(9):51-2. PubMed ID: 8105859
[No Abstract] [Full Text] [Related]
[Next] [New Search]